Astera Labs, Inc. Cash & Equivalents decreased by 11.5% to $148.36M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 70.5%, from $86.99M to $148.36M. Over 3 years (FY 2022 to FY 2025), Cash & Equivalents shows an upward trend with a 30.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $76.09M | $107.60M | $93.68M | $37.72M | $45.10M | $696.08M | $421.08M | $126.12M | $80.04M | $86.99M | $163.40M | $141.48M | $167.68M | $148.36M |
| QoQ Change | — | +41.4% | -12.9% | -59.7% | +19.6% | >999% | -39.5% | -70.0% | -36.5% | +8.7% | +87.8% | -13.4% | +18.5% | -11.5% |
| YoY Change | — | — | — | — | -40.7% | +546.9% | +349.5% | +234.3% | +77.5% | -87.5% | -61.2% | +12.2% | +109.5% | +70.5% |